- AGS Choosing Wisely Workgroup: American Geriatrics Society identifies five things that healthcare providers and patients should question. J Am Geriatr Soc 2013; 61: 622–31.
- AGS Choosing Wisely Workgroup: American Geriatrics Society identifies another five things that healthcare providers and patients should question. J Am Geriatr Soc 2014; 62: 950–60.
- Vance J: AMDA – Choosing Wisely. JAMDA 2013; 14: 639–641.
- www.choosingwisely.org/.
- www.choosingwiselycanada.org recommendations/geriatrics/.
- Gogol M: Choosing Wisely – ein Modell für das deutsche Gesundheitswesen? Z Gerontol Geriatr 2014; 47: 23–6.
- Ellis G, Whitehead MA, Robinson D, et al.: Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ 2011; 343: d6553.
- Deschodt M, Flamaing J, Haentjens P, et al.: Impact of geriatric consultation teams on clinical outcome in acute hospitals: a systematic review and metaanalysis. BMC Med 2013; 11: 48
- Puts MT, Santos B, Hardt J, et al.: An update on a systematic review of the use of geriatric assessment for older adults in oncology. Ann Oncol 2014; 25: 307–15.
- Palumbo A, Bringhen S, Mateos MV, et al.: Geriatric assessment predicts survival and toxicities in elderly myeloma patients: and international Myeloma Working Group report. Blood 2015; 125: 2068–74.
- Van Craen K, Braes T, Wellens N, et al.: The effectiveness of inpatient geriatric evaluation and management units: a systematic review and meta-analysis. J Am Geriatr Soc 2010; 58: 83–92.
- Partridge JS, Harari D, Martin FC, Dhesi JK: The impact of pre-operative comprehensive geriatric assessment on postoperative outcomes in older patients undergoing scheduled surgery: a systematic review. Anaesthesia 2014; 69 (Suppl 1): 8–16.
- Visnjevac O, Lee J, Pourafkari L, et al.: Functional capacity as a significant independent predictor of postoperative mortality of octogenarian ASA-III patients. J Gerontol A Biol Sci Med Sci 2014; 69: 1229–35.
- Joseph B, Pandit V, Zangbar B, et al.: Superiority of frailty over age in predicting outcomes among geriatric trauma patients. JAMA Surg 2014; 149: 83–9.
- Monk TG, Weldon BC, Garvan CW, et al.: Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008; 108: 18–30.
- Gillespie LD, Robertson MC, Gillespie WJ, et al.: Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012; 9: CD007146.
- Health Quality Ontario: Prevention of falls and fall-related injuries in communitydwelling seniors: an evidence-based analysis. Ont Health Technol Assess Ser 2008; 8: 1–78.
- Cameron ID, Gillespie LD, Robertson MC, et al.: Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 2012; 12: CD005465.
- Deandreas S, Bravi F, Turati F, et al.: Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr 2013; 56: 407–15.
- Stubs B, Denkinger M, Brefka S, Dallmeier D: What works to prevent falls in older adults dwelling in long term care facilities and hospitals? An umbrella review of meta-analysis of randomised controlled trials. Maturitas 2015; 81: 335–42.
- Hagen KB, Dagfinrud H, Moe RH, et al.: Exercise therapy for bone and muscle health: an overview of systematic reviews. BMC Med. 2012; 10: 167.
- Sherrington C, Tiedemann A, Fairhall N, et al.: Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations. N S W Public Health Bull 2011; 22: 78–83.
- Liu CJ, Latham NK: Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev 2009; (3): CD002759.
- Borde R, Hortobágyi T, Granacher U: Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med 2015: 45: 1693–720.
- Lesinski M, Hortobágyi T, Muehlbauer T, et al.: Effects of balance training on balance performance in healthy older adults: a systematic review and metaanalysis. Sports Med 2015; 45: 1721–38.
- Bachmann S, Finger C, Huss A, et al.: Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials. BMJ 2010; 340: c1718.
- Avenell A, Mak JC, O’Connell D: Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014; 4: CD000227.
- Murad MH, Elamin KB, Abu Elnour NO, et al.: Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 2997–3006.
- Stockton KA, Mengersen K, Paratz JD, et al.: Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011; 22: 859–71.
- 3Annweiler C, Beauchet O: Questioning vitamin D status of elderly fallers and nonfallers: a meta-analysis to address a „forgotten step“. J Intern Med. 2015; 277: 16–44.
- Halfon M, Phan O, Teta D: Vitamin D: a review on ist effects on muscle strength, the risk of fall, and frailty. Biomed Res Int 2015; 2015: 953241.
- Milne AC, Potter J, Vivanti A, Avenell A: Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev 2009; (2): CD003288.
- Cawood AL, Elia M, Stratton RJ: Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev 2012; 11: 278–96.
- Volkert D, Bauer JM, Frühwald T, et al.: Klinische Ernährung in der Geriatrie. Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM) in Zusammenarbeit mit der GESKES, der AKE und der DGG. Aktuel Ernährungsmed 2013; 38: e1–e48.
- Volkert D, Berner YN, Berry E, et al.: ESPEN guidelines on enteral nutrition: geriatrics. Clin Nutr 2006; 25: 330–60.
- 36. Marshall S, Bauer J, Isenring E: The consequences of malnutrition following discharge from rehabilitation to the community: a systematic review of current evidence in older adults. J Hum Nutr Diet 2014; 27: 133–41.
- Kimber K, Gibbs M, Weekes CE, Baldwin C: Supportive interventions for enhancing dietary intake in malnourished or nutritionally at-risk adults: a systematic review of nonrandomised studies. J Hum Nutr Diet. 2015; 28: 517–45.
- Stratton RJ, Hébuterne X, Elia M: A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev 2013; 12: 884–897.
- DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg.) für die Leitliniengruppe Unipolare Depression: S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 1. Auflage. Version 5.2009, zuletzt verändert: Juni 2015. www.depression.versorgungsleit linien.de; [17.10.2015]; doi: 10.6101/ AZQ/000239.
- Melchior H, Schulz H, Härter M: Faktencheck Gesundheit. Regionale Unterschiede in der Diagnostik und Behandlung von Depressionen. 2014.
- Cooper C, Katona C, Lyketsos K, et al.: A systematic review of treatments for refractory depression in older adults. Am J Psychiatry 2011; 168: 681–8.
- Coupland C, Dhiman P, Moriss R, et al.: Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011; 343: d4551.
- Locher C, Kossowsky J, Gaab J, et al.:Moderation of antidepressant and placebo outcomes by baseline severity in latelife depression: a systematic review and meta-analysis. J Affect Disord 2015; 181: 50–60
- Kirkham JG, Choi N, Seitz D: Meta-analysis of problem solving therapy for the treatment of major depressive disorder in older adults. Int J Geriatr Psychiatry 2016; 31: 526–35.
- Wilson KC, Mottram PG, Vassilas CA: Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev 2008; (1): CD004853.
- Huang AX, Delucchi K, Dunn LB, Nelson JC: A systematic review and meta-analysis of psychotherapy for late-life depression. Am J Geriatr Psychiatry 2015; 23: 261–73.
- Wilkinson P, Izmeth Z: Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev 2012; 11: CD006727.
- Dachverband Osteologie: Prophylaxe, Diagnostik und Therapie der Osteoporose bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e.V. 2014. www.dv-osteologie.org dvo_leitlinien/osteoporose-leitlinie- 2014.
- Pfeilschifter J: Osteoporose-Diagnostik. Was ist neu in der DVO-Leitlinie 2014) Dtsch Med Wochenschr 2015; 140: 1667–71.
- Rush L, McCartney G, Walsh D, MacKay D: Vitamin D and subsequent all-age and premature mortality: a systematic review. BMC Public Health 2013; 13: 679.
- Schöttker B, Ball D, Gellert C, Brenner H: Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2013; 12: 708–18.
- Hadjii P, Claus V, Ziller V, et al.: GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates. Osteoporos Int 2012; 23: 223–31.
- Ziller V, Kostev K, Kyvernitakis I, et al.: Persistence and compliance of medica - tions used in the treatment of osteoporosis – analysis using a large scale, representative, longitudinal German database. Int J Clin Pharmacol Ther 2012; 50: 315–22.
- National Committee for Quality Assurance: Improving quality and patient experience – the state of health care quality 2013. Washington (DC): National Committee for Quality Assurance; Oktober 2013, S. 206.
- Shrank WH, Polinski JM, Avorn J: Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc 2007; 55 (Suppl. 2): S373–82.
- Hajjar ER, Cafiero AC, Hanlon JT: Polypharmacy in elderly patients. Am J Geriatr Pharm 2007; 5: 345–51.
- Steinman MA, Hanlon JT: Managing medications in clinically complex elders: “There’s got to be a happy medium”. JAMA 2010; 304: 1592–601.
- Drenth-van Maanen AC, van Marum RJ, Knol W, et al.: Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy. Drugs Aging 2009; 26: 687–701.
- Patterson SM, Cadogan CA, Kerse N, et al.: Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014; 10: CD008165.
- Santos AP, da Silva DT, Dos Santos Júnior GA, et al.: Evaluation of the heterogeneity of studies estimating the association between risk factors and the use of potentially inappropriate drug therapy for the elderly: a systematic review with meta-analysis. Eur J Clin Pharmacol 2015; 71: 1037–50.
- 61. Boeker EB, Ram K, Klopotowska JE, de et al.: An individual patient data metaanalysis on factors associated with adverse drug events in surgical and nonsurgical inpatients. Br J Clin Pharmacol 2015; 79: 548–57.
- Hanlon JT, Semla TP, Schmader KE: Alternative medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc 2015; 63: e8–18.
- Kuhn-Thiel AM, Weiß C, Wehling M: FORTA authors/expert panel members: Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging 2014; 31: 131–40.
- Wehling M, Burkhardt H, Kuhn-Thiel A, et al.: VALFORTA: a randomized trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing 2016; 45: 262–67.
- O’Mahony D, O’Sullivan D, Byrne S, et al.: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213–18.
- Renom-Guiteras A, Meyer G, Thürmann PA: The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol 2015; 71: 861–75.
- American Geriatrics Society 2015 Beers Criteria Update Expert Panel: American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015; 63: 2227–46.
- Finucane TE, Christmas C, Travis K: Tube feeding in patients with advanced dementia: a review of the evidence. JAMA 1999; 282: 1365–70.
- Gabriel SE, Normand ST: Getting the methods right – the foundation of patientcentered outcomes research. N Engl J Med 2012; 367: 787–90. 23.
- Teno JM, Feng Z, Mitchell SL, et al.: Do financial incentives of introducing case mix reimbursement increase feeding tube use in nursing home residents? J Am Geriatr Soc 2008; 56: 887–90.
- Teno JM, Mitchell SL, Kuo SK, et al.: Decision- making and outcomes of feeding tube insertion: a five-state study. J Am Geriatr Soc 2011; 59: 881–86.
- Palecek EJ, Teno JM, Casarett DJ, et al.: Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 2010; 58: 580–84.
- Hanson LC, Carey TS, Caprio AJ, et al.: Improving decision-making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatr Soc 2011; 59: 2009–16.
- Teno JM, Gozalo PL, Mitchell SL, et al.: Does feeding tube insertion and its timing improve survival? J Am Geriatr Soc 2012; 60: 1918–21.
- Hanson LC, Ersek M, Gilliam R, Carey TS: Oral feeding options for people with dementia: a systematic review. J Am Geriatr Soc 2011; 59: 463–72.
- Palecek EJ, Teno JM, Casarett DJ, et al.: Comfort feeding only: a proposal to bring clarity to decision-making regarding difficulty with eating for persons with advanced dementia. J Am Geriatr Soc 2010; 58: 580–84.
- Sorrell JM: Use of feeding tubes in patients with advanced dementia: are we doing harm? J Psychosoc Nurs Ment Health Serv 2010; 48: 15–8.
- Sampson EL, Candy B, Jones L: Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev 2009; (2): CD007209.
- Gillick MR, Volandes AE: The standard of caring: why do we still use feeding tubes in patients with advanced dementia? J Am Med Dir Assoc 2008; 9: 364–67.
- 80. Ganzini L: Artificial nutrition and hydration at the end of life: ethics and evidence. Palliat Support Care 2006; 4: 135–43.
- Li I: Feeding tubes in patients with severe dementia. Am Fam Physician 2002; 65: 1605–11.
- Mitchell SL, Kiely DK, Lipsitz LA: The risk factors and impact on survival of feeding tube placement in nursing home residents with severe cognitive impairment. Arch Intern Med 1997; 157: 327–32.
- National Institute for Health and Clinical Excellence and Social Care Institute for Excellence NICE-SCIE: National Collaborating Centre for Mental Health. Clinical guidelines 42: Dementia: Supporting people with dementia and their carers in health and social care. London 2006: Amended 2011. www.nice.org.uk/CG042.
- Maher A, Maglione M, Bagley S, et al.: Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 2011; 306: 1359–69.
- Schneider LS, Tariot PN, Dagerman KS, et al.: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med 2006; 355: 1525–38.
- Gitlin LN, Kales HC, Lyketsos, CG: Nonpharmacologic management of behavioral symptoms in dementia. JAMA 2012; 308: 2020–29.
- American Medical Directors Association: Dementia in the long term care setting clinical practice guideline. Columbia, MD: AMDA 2012. www.amda. com/education/moodandbehavior/AM DA%20CPG_Dementia.pdf
- Flaherty J, Gonzales J, Dong B: Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review. J Am Geriatr Soc 2011; 59 (Suppl 2): S269–76.
- Ozbolt LB, Paniagua MA, Kaiser RM: Atypical antipsychotics for the treatment of delirious elders. J Am Med Dir Assoc 2008; 9: 18–28.
- Schneeweiss S, Setoguchi S, Brookhart A, et al.: Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007; 176: 627–32.
- Gill SS, Bronskill SE, Normand SL, et al.: Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775–86.
- Schneider LS, Dagerman K, Insel PS: Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006; 14: 191–210.
- Sink KM, Holden KF, Yaffe K: Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293: 596–608.
- Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43.
- Kales HC, Gitlin LN, Lyketsos CG, Detroit Expert Panel on the Assessment and Management of the Neuropsychiatric Symptoms of Dementia: Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 2014; 62: 762–69.
- Schröder FH, Hugosson J, Roobol MJ, et al.: Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012; 366: 981–90.
- Moyer VA, U.S. Preventive Services Task Force: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120–34.
- Walter LC, Covinsky KE: Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285: 2750–56.
- Lee SJ, Boscardin WJ, Stijacic-Cenzer I, et al.: Time lag to benefit after screening for breast and colorectal cancer: metaanalysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 2012; 346: e8441.
- van Hees F, Habbema JD, Meester RG, et al.: Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med 2014; 160: 750–9.
- National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al.: Reduced lung-cancer mortality with lowdose computed tomographic screening. N Engl J Med 2011; 365: 395–409.
- Woolf SH, Harris RP, Campos-Outcalt D: Low-dose lung computed tomography screening for lung cancer: how strong is the evidence? JAMA Intern Med 2014; 174: 2019–22.
- Clarfield AM: Screening in frail older people: an ounce of prevention or a pound of trouble? J Am Geriatr Soc 2010; 58: 2016–21.
- Gill TM: The central role of prognosis in clinical decision making. JAMA 2012; 307: 199–200.
- Gross CP: Cancer screening in older persons: a new age of wonder. JAMA Intern Med 2014; 174: 1565–67.
- Lee SJ, Leipzig RM, Walter LC: Incorporating lag time to benefit into prevention decision for older adults. JAMA 2013; 310: 2609–10.
- Lonsdorp-Vogelaar I, Gulati R, Mariotto AB, et al.: Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 2014; 161: 104–12.
- Royce TJ, Hendrix LH, Stokes WA, et al.: Cancer screening rates in individuals with different life expectancies. JAMA Intern Med 2014; 174: 1558–65.
- Finkle WD, Der JS, Greenland S, et al.: Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam or diazepam in older adults. J Am Geriatr Soc 2011; 59: 1883–90.
- Allain H, Bentue-Ferrer D, Polard E, et al.: Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging 2005; 22: 749–65.
- Kripke DF, Langer RD, Kline LE. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open 2012; 2: e000850.
- Glass J, Lanctôt KL, Herrmann N, et al.: Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169.
- Sivertsen B, Omvik S, Pallesen S, et al.: Cognitive behavioral therapy vs zopi - clone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006; 295: 2851–58.